|
Re: New version of May slide deck and ERA-EDTA Conference & Symposium
|
3
|
Resverlogix Corp.
|
Jun 27, 2018 04:23PM
|
|
Re: Priceless on I.V. Regarding Zenith
|
3
|
Zenith Epigenetics
|
Apr 08, 2017 12:29PM
|
|
New Corporate Update Slide Deck
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 11, 2019 11:29AM
|
|
Re: AGM Presentation
|
3
|
Resverlogix Corp.
|
Dec 12, 2017 04:19PM
|
|
Re: Zenith/Pfizer
|
3
|
Zenith Epigenetics
|
Feb 18, 2019 05:22PM
|
|
Re: Precedence in Gene Therapy Pricing
|
3
|
Resverlogix Corp.
|
Jan 03, 2018 12:43PM
|
|
Re: An invitation to join the conversation here on Agoracom
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2018 12:19PM
|
|
Re: Why didn't management do some phase 2's,....
|
3
|
Resverlogix Corp.
|
Jun 19, 2019 09:19PM
|
|
Re: Insider Selling
|
3
|
Resverlogix Corp.
|
Jul 14, 2019 02:05PM
|
|
Re: Gasoline
|
3
|
Zenith Epigenetics
|
Feb 09, 2017 02:15PM
|
|
Re: … well, where are we at...?..
|
3
|
Resverlogix Corp.
|
Jun 10, 2015 02:21PM
|
|
Compliment in Human Disease meeting at end of this month
|
3
|
Resverlogix Corp.
|
Jun 18, 2015 03:51PM
|
|
Re: ...isn't this interesting...
|
3
|
Resverlogix Corp.
|
Jul 07, 2015 12:24AM
|
|
Re: I'm pretty sure this question has been covered....
|
3
|
Resverlogix Corp.
|
Aug 01, 2017 10:54AM
|
|
Re: Explanation?
|
3
|
Resverlogix Corp.
|
Oct 05, 2017 01:48PM
|
|
Re: Use of Caps Lock is not permitted
|
3
|
Resverlogix Corp.
|
Sep 12, 2019 04:29PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
3
|
Resverlogix Corp.
|
Dec 02, 2021 10:46AM
|
|
Re: What is amazing is the size the Chronic Kidney disease market,...
|
3
|
Resverlogix Corp.
|
Mar 25, 2019 09:32PM
|
|
Re: 15 Months
|
3
|
Zenith Epigenetics
|
Sep 15, 2017 04:54PM
|
|
Re: What Jardiance/EMPA-REG Outcome means for RVX-208
|
3
|
Resverlogix Corp.
|
Sep 18, 2015 01:45PM
|
